Recordati to Seek Canadian Approval for Kidney Disease Drug Recordati to Seek Canadian Approval for Kidney Disease Drug

Italy ' s Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma, which makes the only drug approved for treatment in Canada.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Nephrology News Source Type: news